What's in Rebiotix Inc.'s pipeline?

Rebiotix Inc. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Rebiotix Inc.'s portfolio?

Top competitors by shared drug class: Ardeypharm GmbH, Assistance Publique - Hôpitaux de Paris, Bausch Health Americas, Inc., BioVersys AG, Bosnalijek D.D.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/rebiotix-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Rebiotix Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rebiotix Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
RBX2660	RBX2660	phase 3	Live biotherapeutic product		Infectious Disease / Gastroenterology
Standard of Care Antibiotics	Standard of Care Antibiotics	phase 3	Antibiotic	Bacterial cell wall enzymes or proteins	Infectious Diseases

Therapeutic area mix

Infectious Disease / Gastroenterology · 1
Infectious Diseases · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ardeypharm GmbH · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Bausch Health Americas, Inc. · 1 shared drug class
BioVersys AG · 1 shared drug class
Bosnalijek D.D · 1 shared drug class
Capital Medical University · 1 shared drug class
Dr. Reddy's Laboratories Limited · 1 shared drug class
Achaogen, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Rebiotix Inc.:

Cite this brief

Drug Landscape (2026). Rebiotix Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/rebiotix-inc. Accessed 2026-06-10.